Thyrotropin suppression therapy for papillary thyroid carcinoma with a huge recurred neck lymph node

Area of Science:

• Endocrinology
• Oncology
• Thyroid Cancer Research

Background:

• Differentiated thyroid cancer (DTC) management often involves thyroidectomy followed by TSH suppression therapy.
• Thyroid-stimulating hormone (TSH) plays a crucial role in the growth of DTC.
• Recurrent DTC poses a significant clinical challenge, especially in patients with high surgical risks.

Observation:

• A 57-year-old woman with a large recurrent lymph node in her neck due to DTC was treated with TSH suppression therapy.
• The patient had a high risk of surgical complications, making TSH suppression a preferred option.
• The large neck lymph node showed a significant response and decreased in size after initiating TSH suppression therapy.

Findings:

• TSH suppression therapy led to a measurable reduction in the size of the recurrent lymph node.
• The patient was monitored for 144 months, indicating the long-term potential of this treatment.
• The study highlights the efficacy of TSH suppression in managing recurrent DTC.

Implications:

• TSH suppression therapy can be considered a valuable alternative treatment for recurrent DTC, particularly in high-risk surgical patients.
• This therapeutic strategy may help avoid surgical complications and improve disease management.
• Further research into TSH suppression as a primary or adjuvant therapy for DTC is warranted.